Last update 08 May 2025
Fusion Biotech Co. Ltd.

Fusion Biotech Co. Ltd.

Holding Company|Ulsan, South Korea|
www.fusionbiotechnology.com

Overview

Tags

Eye Diseases
Congenital Disorders
Neoplasms
Small molecule drug
Recombinant protein
Fusion protein

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Top 5 Drug TypeCount
Small molecule drug4
Recombinant protein2
Fusion protein1
Top 5 TargetCount
ROS1(Proto-oncogene tyrosine-protein kinase ROS)2
VEGFR2(Vascular endothelial growth factor receptor 2)1
YAP1(Yes1 associated transcriptional regulator)1
MDM2(p53-binding protein Mdm-2)1

Related

7
Drugs associated with Fusion Biotech Co. Ltd.
FBT-SP101
Target
ROS1
Mechanism
ROS1 modulators
Active Org.
Fusion Biotech Co. Ltd.Fusion Biotech Co. Ltd.
Originator Org.
Fusion Biotech Co. Ltd.Fusion Biotech Co. Ltd.
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
FBT-VR(HR)
Target
VEGFR2
Mechanism
VEGFR2 antagonists
Active Org.
Fusion Biotech Co. Ltd.Fusion Biotech Co. Ltd.
Originator Org.
Fusion Biotech Co. Ltd.Fusion Biotech Co. Ltd.
Active Indication
Wet age-related macular degeneration
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
FBT-NuNi
Target
MDM2
Mechanism
MDM2 inhibitors
Active Org.
Fusion Biotech Co. Ltd.Fusion Biotech Co. Ltd.
Originator Org.
Fusion Biotech Co. Ltd.Fusion Biotech Co. Ltd.
Active Indication
dry age-related macular degeneration
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Fusion Biotech Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Fusion Biotech Co. Ltd.
Login to view more data
100 Deals associated with Fusion Biotech Co. Ltd.
Login to view more data
100 Translational Medicine associated with Fusion Biotech Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
4
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
FBT-SP201
 ( ROS1 )		-
Preclinical
FBT-NuNi
 ( MDM2 )		dry age-related macular degeneration
More
Preclinical
FBT-SP101
 ( ROS1 )		-
Preclinical
FBT-VR(HR)
 ( VEGFR2 )		Wet age-related macular degeneration
More
Preclinical
FBT-ER-ProNP
Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free